Efficacy News and Research

RSS
Final Atlantis space trip may open new era of research into infectious diseases

Final Atlantis space trip may open new era of research into infectious diseases

Eighteen scientists receive Damon Runyon Cancer Research Foundation awards

Eighteen scientists receive Damon Runyon Cancer Research Foundation awards

Freeze-dried gene therapy system safe and effective for treating brain cancer

Freeze-dried gene therapy system safe and effective for treating brain cancer

Treating migraines with behavioral approaches can make financial sense

Treating migraines with behavioral approaches can make financial sense

New biological insights into fat tissue

New biological insights into fat tissue

Antimicrobial copper surfaces reduce risk of acquiring hospital infection

Antimicrobial copper surfaces reduce risk of acquiring hospital infection

Novel drug delivery device can treat diabetes-related retinal damage

Novel drug delivery device can treat diabetes-related retinal damage

Small molecule treatment holds promise for Usher syndrome

Small molecule treatment holds promise for Usher syndrome

Lantheus commences flurpiridaz F 18 PET MPI Phase 3 trial for detection of coronary artery disease

Lantheus commences flurpiridaz F 18 PET MPI Phase 3 trial for detection of coronary artery disease

Positive topline results from Alkermes ALKS 9070 phase 1b study for schizophrenia

Positive topline results from Alkermes ALKS 9070 phase 1b study for schizophrenia

Positive final results from Medicago's H5N1 Avian Influenza VLP vaccine Phase II trial

Positive final results from Medicago's H5N1 Avian Influenza VLP vaccine Phase II trial

VIVUS submits avanafil NDA to FDA for treatment of erectile dysfunction

VIVUS submits avanafil NDA to FDA for treatment of erectile dysfunction

MR-guided focused ultrasound effective for treating essential tremor

MR-guided focused ultrasound effective for treating essential tremor

Novartis reports NVA237 Phase III trial results against COPD

Novartis reports NVA237 Phase III trial results against COPD

Almirall, Forest Labs submit aclidinium bromide NDA to FDA for treatment of COPD

Almirall, Forest Labs submit aclidinium bromide NDA to FDA for treatment of COPD

Sensitivity of bladder cancer cells linked to chemotherapy and expression of miR-34a gene

Sensitivity of bladder cancer cells linked to chemotherapy and expression of miR-34a gene

Physicians urge FDA not to approve Truvada as an HIV prevention pill

Physicians urge FDA not to approve Truvada as an HIV prevention pill

Early metformin treatment may prevent adolescent polycystic ovary syndrome

Early metformin treatment may prevent adolescent polycystic ovary syndrome

Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis

Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis

Threshold commences combination Phase 1/2 trial of TH-302 and sunitinib for RCC, GIST and PNET

Threshold commences combination Phase 1/2 trial of TH-302 and sunitinib for RCC, GIST and PNET

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.